Barclays lowered the firm’s price target on UnitedHealth (UNH) to $560 from $642 and keeps an Overweight rating on the shares following the Q1 report.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UNH:
- UnitedHealth’s Stock (UNH) Plunge Drives Historic Dow Jones Decline
- UnitedHealth price target lowered to $525 from $612 at UBS
- Stock Market Recap: Eli Lilly Soars, UnitedHealth Crashes, Financials Lead Sector Gains
- ‘Don’t Miss This Selloff,’ Says Investor About UnitedHealth Stock
- UnitedHealth Stock Plummets Amid Earnings Challenges